Biotechnology News

February 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Entest BioMedical Inc. (OTCQB: ENTB), a veterinary biotechnology company and operator of veterinary hospitals, today announced the declaration of a dividend of one share of the Company’s Series B Preferred Stock for...

February 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 14th Annual BIO CEO & Investor Conference on Tuesday...

February 10, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 14th Annual BIO CEO & Investor Conference will be webcast and may be accessed at...

February 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will move the timing of its conference call with investors to start at 1:30 p.m. PST (4:30 p.m. EST) on February 14, 2012.

February 10, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 fourth quarter financial results before the opening of the market on February 15, 2012. The Company will host a conference call at 8:00 a.m.,...

February 10, 2012

ZURICH & AMSTERDAM--(BUSINESS WIRE)--Investment community to come out in full force at BIO-Europe Spring® 2012

February 10, 2012

--(BUSINESS WIRE)--Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.

February 10, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Leerink Swann Global Healthcare Conference. The live presentation will occur at 10:30...

February 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme today announced its participation in the Leerink Swann 2012 Global Healthcare Conference, the Citi 2012 Global Healthcare Conference, and the Oncology Partnering & Deal Making Conference.

February 10, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Leerink Swann 2012 Global Healthcare Conference in New...

February 10, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the acquisition of ECG Scanning &...

February 10, 2012

SOUTH SAN FRANCISCO, Calif. & BRUSSELS--(BUSINESS WIRE)--Nodality, Inc. and UCB Pharma S.A. (Euronext Brussels: UCB) today announced a strategic collaboration utilizing Nodality’s proprietary Single Cell Network Profiling (SCNP) technology to...

February 10, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), today provided an update on the status of the development and commercialization agreement with Genzyme, a Sanofi company. On Wednesday, February 8, 2012, Sanofi issued a...

February 9, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its President and Chief Scientific Officer, Kevin Koch, will speak at the Leerink Swann Healthcare Conference in New York. The public is welcome to...

February 9, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will be participating in “fireside chat” forums at two upcoming investor...

February 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus and Hydra Biosciences collaborate to advance development of Zalicus’ preclinical ion channel modulator product candidates for the treatment of pain.

February 9, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE AMEX: CVM) reports financial results for the fiscal quarter ended December 31, 2011. CEL-SCI reported that net loss available to shareholders for the quarter ended December 31, 2011 was ($4,...

February 9, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced encouraging safety and tolerability data as...

February 9, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq:EXEL) today announced that it plans to offer, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering. The company...

February 9, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology and obesity, today announced financial results for its fiscal 2012 first quarter ended December 31,...

February 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2011, and company highlights. “2011 was a...

February 9, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Leerink Swann 2012 Global Healthcare Conference on Thursday, Feb. 16, 2012, at 3:00 p.m. EST (8:00 p.m. GMT) from the...

February 9, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer of Ligand will present at the BIO CEO and Investor Conference on Monday, February 13, 2012 at...

February 9, 2012

--(BUSINESS WIRE)--Psoriasis affects as many as 7.5 million Americans--but they can get help to manage it once they take the first step.

February 9, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) announced today that it will disclose preliminary financial results for the third quarter of fiscal year 2012 on Tuesday, February 21, 2012, before the market opens. The Company...

February 9, 2012

EDINBURGH, SCOTLAND & WILMINGTON, N.C.--(BUSINESS WIRE)--The Scottish government and Pharmaceutical Product Development, LLC (PPD) announced a unique alliance designed to increase the amount of clinical research conducted in Scotland.

February 9, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced today the pricing of an underwritten public offering of 20,000,000 primary shares of its common stock at a public offering price of $2.60 per share. The gross proceeds...

February 9, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis to Present at BIO CEO & Investor

February 9, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will participate with other industry executives in...

February 9, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 3:30 p.m....

February 9, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces presentation at Leerink Swann 2012 Global Healthcare Conference.

February 9, 2012

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc. today announced that it has entered into a strategic collaboration with Tetracore, Inc. to develop a next generation biothreat assay.

February 9, 2012

BOSTON--(BUSINESS WIRE)--Acetylon Pharmaceuticals announced that Celgene Corporation (NASDAQ: CELG) will invest a total of $15 million in Acetylon via the purchase of Series B-2 Preferred Stock.

February 9, 2012

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--New Southern California company specializes in medical-grade, blow molded plastic parts for the biopharmaceutical and life science industries.

February 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that its scientists have discovered a novel method for monitoring RNAi activity in blood samples, representing a...

February 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced that Duncan Higgons, chief operating officer, is...

February 9, 2012

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the 14th Annual...

February 9, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast...

February 9, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--PaxVax, developer of innovative and socially responsible oral vaccines against infectious diseases, announced the expansion of its executive management team.

February 9, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that its president and...

February 9, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo will webcast its corporate presentation at the 14th Annual BIO CEO + Investor Conference, on Monday, Feb. 13, at 8:30 am Eastern.

February 9, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has received a Paragraph IV Notice Letter from Hospira, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic...

February 9, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Leerink Swann 2012 Global Healthcare Conference in New York, New York, on February 16, 2012. Charles J. Dockendorff,...

February 9, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics, Inc. (OTC: GALT), the leading developer of therapeutics that target galectin receptors to treat cancer and fibrosis, today announced that Dr. Peter G. Traber, Chief Executive Officer,...

February 9, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN): Fourth Quarter 2011 Financial Highlights: Q4 2011 net product sales increased 46 percent to $227.6 million, compared to $156.0 million in Q4 2010. Q4 2011 GAAP net...

February 9, 2012

--(BUSINESS WIRE)--Date:   Thursday, February 9, 2012   Time: 1:00 to 2:00 p.m.   Location: Chromocell Corporation 685 U.S. Highway One North Brunswick, NJ 08902 CLICK HERE for directions   What: U.S. Assistant Secretary of Labor for Employment...

February 9, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica reports record service revenue for the fourth quarter and year end 2011, along with its full financial results for the year ended December 31, 2011.

February 9, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012 at 4:00 pm ET...